ロード中...
Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis
BACKGROUND: Concomitant use of oral azithromycin and inhaled tobramycin occurs in approximately half of US cystic fibrosis (CF) patients. Recent data suggest that this combination may be antagonistic. METHODS: Test the hypothesis that azithromycin reduces the clinical benefits of tobramycin by analy...
保存先:
| 出版年: | J Cyst Fibros |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5492972/ https://ncbi.nlm.nih.gov/pubmed/28025037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2016.12.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|